An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects With Intermediate Age-Related Macular Degeneration
Clinical trial NCT02848313 · COMPLETED
Trial details
- NCT number
- NCT02848313
- Sponsor
- Stealth BioTherapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-28
- Primary completion
- 2018-03-16
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.